
Cellular Origins appoints Peter Crossley as chief operating officer
Betsy Goodfellow | January 25, 2024 | Appointment | Business Services | Cellular Origins, Peter Crossley, appointment, chief operating officer
Cellular Origins, a TTP Company, has announced that it has appointed Peter Crossley as chief operating officer (COO).
Peter brings with him 27 years of experience in novel technology and product development, and aims to continue the company’s goal of developing scalable automation solutions for cell therapy manufacturing in order to improve patient access to these therapies. In this role, Peter will lead the development and delivery of the company’s products “by driving team growth and overseeing people development,” according to the company’s press release.
Prior to this role, Peter worked as a consultant at TTP for 17 years, and has been interim chief technology officer at Depixus.
Commenting on his new appointment, Peter Crossley stated: “Cellular Origins is in an exciting phase of growth. As COO, I look forward to driving the expansion of Cellular Origins’ world-class team, as well as supporting them to bring about a revolution in cell therapy manufacture that will deliver these life changing treatments to all who need them.”
Dr Edwin Stone, Cellular Origins’ chief executive officer, added: “I am delighted to welcome Peter. His proven cross-sector experience, leadership skills, and ability to turn ground-breaking innovation into commercial reality will accelerate our mission to develop scalable automation solutions for cell therapies.”
Betsy Goodfellow
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






